Search Tag: Afrezza

Pharmacy Management

2014 14 Nov

MannKind and Sanofi are set to launch their inhalable insulin product. Approved earlier this year by the FDA, Afrezza is a fast-acting insulin to be taken at mealtimes. The drug is effective for both Type 1 and Type 2 diabetes. Seven years ago, Pfizer launched Exubera, another inhalable insulin. When Exubera was introduced, it was believed to...Read more